Activin betaC-subunit heterodimers provide a new mechanism of regulating activin levels in the prostate
- PMID: 12960042
- DOI: 10.1210/en.2003-0225
Activin betaC-subunit heterodimers provide a new mechanism of regulating activin levels in the prostate
Abstract
Activins are formed by dimerization of beta-subunits and, as members of the TGF-beta superfamily, have diverse roles as potent growth and differentiation factors. As the biological function of the activin C homodimer (betaC-betaC) is unknown, we sought to compare activin A (betaA-betaA), B (betaB-betaB), and C homodimer bioactivities and to investigate the consequences of activin betaC-subunit overexpression in prostate tumor cells. Exogenous activin A and B homodimers inhibited cell growth and activated activin-responsive promoters. In contrast, the activin C homodimer was unable to elicit these responses. We previously showed that the activin betaC-subunit heterodimerized with activin betaA in vitro to form activin AC. Therefore, we hypothesize that the activin betaC-subunit regulates the levels of bioactive activin A by the formation of activin AC heterodimers. To test this hypothesis, we measured activin AC heterodimer production using a novel specific two-site ELISA that we developed for this purpose. In the PC3 human prostate tumor cell line, activin betaC-subunit overexpression increased activin AC heterodimer levels, concomitantly reduced activin A levels, and decreased activin signaling. Overall, these data are consistent with a role for the activin betaC-subunit as a regulatory mechanism to reduce activin A secretion via intracellular heterodimerization.
Similar articles
-
Should activin betaC be more than a fading snapshot in the activin/TGFbeta family album?Cytokine Growth Factor Rev. 2005 Aug-Oct;16(4-5):377-85. doi: 10.1016/j.cytogfr.2005.04.005. Cytokine Growth Factor Rev. 2005. PMID: 15925536 Review.
-
Beta A versus beta B: is it merely a matter of expression?Mol Cell Endocrinol. 2004 Oct 15;225(1-2):9-17. doi: 10.1016/j.mce.2004.02.007. Mol Cell Endocrinol. 2004. PMID: 15451562 Review.
-
Over-Expression of Activin-βC Is Associated with Murine and Human Prostate Disease.Horm Cancer. 2017 Apr;8(2):100-107. doi: 10.1007/s12672-017-0283-8. Epub 2017 Jan 23. Horm Cancer. 2017. PMID: 28116672 Free PMC article.
-
Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in humanprostate and evidence for formation of new activin heterodimers of beta(C)-subunit.J Clin Endocrinol Metab. 2000 Dec;85(12):4851-8. doi: 10.1210/jcem.85.12.7052. J Clin Endocrinol Metab. 2000. PMID: 11134153
-
Effects of recombinant activins on steroidogenesis in human granulosa-lutein cells.J Clin Endocrinol Metab. 2014 Oct;99(10):E1922-32. doi: 10.1210/jc.2014-1223. Epub 2014 Jul 25. J Clin Endocrinol Metab. 2014. PMID: 25062451
Cited by
-
Activins and Inhibins: Roles in Development, Physiology, and Disease.Cold Spring Harb Perspect Biol. 2016 Jul 1;8(7):a021881. doi: 10.1101/cshperspect.a021881. Cold Spring Harb Perspect Biol. 2016. PMID: 27328872 Free PMC article. Review.
-
Activin E is a transforming growth factor β ligand that signals specifically through activin receptor-like kinase 7.Biochem J. 2024 Apr 10;481(7):547-564. doi: 10.1042/BCJ20230404. Biochem J. 2024. PMID: 38533769 Free PMC article.
-
The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding.EMBO J. 2009 Sep 2;28(17):2662-76. doi: 10.1038/emboj.2009.205. Epub 2009 Jul 30. EMBO J. 2009. PMID: 19644449 Free PMC article.
-
Rat activin-betaE mRNA expression during development and in acute and chronic liver injury.J Mol Genet Med. 2006 Apr 12;2(1):93-100. doi: 10.4172/1747-0862.1000019. J Mol Genet Med. 2006. PMID: 19565003 Free PMC article.
-
Activins and follistatins: Emerging roles in liver physiology and cancer.World J Hepatol. 2009 Oct 31;1(1):17-27. doi: 10.4254/wjh.v1.i1.17. World J Hepatol. 2009. PMID: 21160961 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials